Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study

Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study

Xianhua Liao,1 Qianqian Ma,1 Tingfeng Wu,1 Congxiang Shao,1 Yansong Lin,1 Yanhong Sun,2 Shiting Feng,3 Wei Wang,4 Junzhao Ye,1 Bihui Zhong1 1Department of Gastroenterology of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China; 2Department of Laboratory of Th...

Full description

Bibliographic Details
Main Authors: Liao X, Ma Q, Wu T, Shao C, Lin Y, Sun Y, Feng S, Wang W, Ye J, Zhong B
Format: Article
Language:English
Published: Dove Medical Press 2022-04-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
dyslipidemia
metabolic dysfunction-associated fatty liver disease
alanine aminotransferase
triglyceride
gamma glutamyl transpeptidase
statins
Online Access:https://www.dovepress.com/lipid-lowering-responses-to-dyslipidemia-determine-the-efficacy-on-liv-peer-reviewed-fulltext-article-DMSO

Internet

https://www.dovepress.com/lipid-lowering-responses-to-dyslipidemia-determine-the-efficacy-on-liv-peer-reviewed-fulltext-article-DMSO

Similar Items